{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:34:04Z","timestamp":1793014444838,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Higher Education Research Modernization Scheme","award":["Research Modernization-2017\/2018"],"award-info":[{"award-number":["Research Modernization-2017\/2018"]}]},{"name":"Higher Education Research Modernization Scheme","award":["Research Modernization-2017\/2018"],"award-info":[{"award-number":["Research Modernization-2017\/2018"]}]},{"name":"Higher Education Research Modernization Scheme","award":["Research Modernization-2017\/2018"],"award-info":[{"award-number":["Research Modernization-2017\/2018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Molecular hybridization of privileged scaffolds may generate novel antiplasmodial chemotypes that display superior biological activity and delay drug resistance. In the present study, we describe the in vitro activities and mode of action of 3\u2032,4\u2032-dihydro-2\u2032H-spiro[indoline-3,1\u2032-isoquinolin]-2-ones, a novel class of spirofused tetrahydroisoquinoline\u2013oxindole hybrids, as novel antimalarial agents. Whole cell phenotypic screening of these compounds identified (14b), subsequently named (\u00b1)-moxiquindole, as the most potent compound in the current series with equipotent antiplasmodial activity against both chloroquine sensitive and multidrug resistant parasite strains with good selectivity. The compound was active against all asexual stages of the parasite including inhibition of merozoite egress. Additionally, (\u00b1)-moxiquindole exhibited significant inhibitory effects on hemoglobin degradation, and disrupted vacuolar lipid dynamics. Taken together, our data confirm the antiplasmodial activity of (\u00b1)-moxiquindole, and identify 3\u20324\u2032-dihydro-2\u2032H-spiro[indoline-3,1\u2032-isoquinolin]-2-ones as a novel class of antimalarial agents with multiple modes of action.<\/jats:p>","DOI":"10.1038\/s41598-020-74824-0","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T10:04:15Z","timestamp":1603274655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Spirofused tetrahydroisoquinoline-oxindole hybrids as a novel class of fast acting antimalarial agents with multiple modes of action"],"prefix":"10.1038","volume":"10","author":[{"given":"Noella M.","family":"Efange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maloba M. M.","family":"Lobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigue","family":"Keumoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Ayong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M. N.","family":"Efange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"74824_CR1","unstructured":"World Health Organization. World malaria report 2019. Report No.: ISBN 978-92-4-156572-1."},{"key":"74824_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/tropicalmed4020089","volume":"4","author":"LE Heller","year":"2019","unstructured":"Heller, L. E. & Roepe, P. D. Artemisinin-based antimalarial drug therapy: molecular pharmacology and evolving resistance. Trop. Med. Infect. Dis. 4, 89. https:\/\/doi.org\/10.3390\/tropicalmed4020089 (2019).","journal-title":"Trop. Med. Infect. Dis."},{"key":"74824_CR3","unstructured":"WHO. World malaria report 2018 (2018)."},{"key":"74824_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"A Chanaki","year":"2016","unstructured":"Chanaki, A. et al. Dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect. Dis. 16, 357\u2013365. https:\/\/doi.org\/10.1016\/S1473-3099(15)00487-9 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"74824_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/infdis\/jiu491","volume":"211","author":"S Takala-Harrison","year":"2014","unstructured":"Takala-Harrison, S. et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J. Infect. Dis. 211, 670\u2013679. https:\/\/doi.org\/10.1093\/infdis\/jiu491 (2014).","journal-title":"J. Infect. Dis."},{"key":"74824_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","volume":"15","author":"KM Tun","year":"2015","unstructured":"Tun, K. M. et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect. Dis. 15, 415\u2013421. https:\/\/doi.org\/10.1016\/S1473-3099(15)70032-0 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"74824_CR7","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1021\/jm00120a002","volume":"31","author":"BE Evans","year":"1988","unstructured":"Evans, B. E. et al. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J. Med. Chem. 31, 2235\u20132246. https:\/\/doi.org\/10.1021\/jm00120a002 (1988).","journal-title":"J. Med. Chem."},{"key":"74824_CR8","doi-asserted-by":"publisher","first-page":"111983","DOI":"10.1016\/j.ejmech.2019.111983","volume":"188","author":"NS Tibon","year":"2020","unstructured":"Tibon, N. S., Ng, C. H. & Cheong, S. L. Current progress in antimalarial pharmacotherapy and multi-target drug discovery. Eur. J. Med. Chem. 188, 111983. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111983 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"74824_CR9","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.2174\/1568026616666160927160620","volume":"17","author":"MO Pedrosa","year":"2017","unstructured":"Pedrosa, M. O. et al. Hybrid compounds as direct multitarget ligands: a review. Curr. Top. Med. Chem. 17, 1044\u20131079. https:\/\/doi.org\/10.2174\/1568026616666160927160620 (2017).","journal-title":"Curr. Top. Med. Chem."},{"key":"74824_CR10","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.11932250","volume":"329","author":"M Rottmann","year":"2010","unstructured":"Rottmann, M. et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175\u20131180. https:\/\/doi.org\/10.1126\/science.11932250 (2010).","journal-title":"Science"},{"key":"74824_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4155\/fmc.15.177","volume":"8","author":"H Turner","year":"2016","unstructured":"Turner, H. Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4. Future Med. Chem. 8, 227\u2013238. https:\/\/doi.org\/10.4155\/fmc.15.177 (2016).","journal-title":"Future Med. Chem."},{"key":"74824_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.fitote.2015.09.014","volume":"106","author":"SRM Ibrahim","year":"2015","unstructured":"Ibrahim, S. R. M. & Mohamed, G. A. Naphthylisoquinoline alkaloids potential drug leads. Fitoterapia 106, 194\u2013225. https:\/\/doi.org\/10.1016\/j.fitote.2015.09.014 (2015).","journal-title":"Fitoterapia"},{"key":"74824_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1021\/acs.jnatprod.6b00967","volume":"80","author":"J Li","year":"2017","unstructured":"Li, J. et al. Dioncophyllines C2, D2, and F and related Naphthylisoquinoline alkaloids from the congolese liana Ancistrocladus ileboensis with potent activities against Plasmodium falciparum and against multiple myeloma and leukemia cell lines. J. Natl. Prod. 80, 443\u2013458. https:\/\/doi.org\/10.1021\/acs.jnatprod.6b00967 (2017).","journal-title":"J. Natl. Prod."},{"key":"74824_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.fitote.11.006","volume":"131","author":"S Fayez","year":"2018","unstructured":"Fayez, S. et al. Ancistrobrevines E-J and related naphthylisoquinoline alkaloids from the West African liana Ancistrocladus abbreviatus with inhibitory activities against Plasmodium falciparum and PANC-1 human pancreatic cancer cells. Fitoterapia 131, 245\u2013259. https:\/\/doi.org\/10.1016\/j.fitote.11.006 (2018).","journal-title":"Fitoterapia"},{"key":"74824_CR15","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1128\/AAC.41.11.2533","volume":"41","author":"G Fran\u00e7ois","year":"1997","unstructured":"Fran\u00e7ois, G. et al. Naphthylisoquinoline alkaloids against malaria: evaluation of the curative potentials of Dioncophylline C and Dioncopeltine A against Plasmodium berghei in vivo. Antimicrob. Agents Chemother. 41, 2533\u20132539 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"74824_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s00207519(96)00171-3","volume":"27","author":"G Fran\u00e7ois","year":"1997","unstructured":"Fran\u00e7ois, G. et al. Retarded development of exoerythrocytic stages of the rodent malaria parasite Plasmodium berghei in human hepatoma cells by extracts from Dioncophyllaceae and Ancistrocladaceae species. Int. J. Parasitol. 27, 29\u201332. https:\/\/doi.org\/10.1016\/s00207519(96)00171-3 (1997).","journal-title":"Int. J. Parasitol."},{"key":"74824_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s004360050661","volume":"85","author":"G Fran\u00e7ois","year":"1999","unstructured":"Fran\u00e7ois, G. et al. Differential sensitivity of erythrocytic stages of the rodent malaria parasite Plasmodium chabaudi chabaudi to dioncophylline B, a highly active naphthylisoquinoline alkaloid. Parasitol. Res. 85, 935\u2013941 (1999).","journal-title":"Parasitol. Res."},{"key":"74824_CR18","doi-asserted-by":"publisher","first-page":"191316","DOI":"10.1098\/rsos.191316","volume":"7","author":"MMM Lobe","year":"2020","unstructured":"Lobe, M. M. M. & Efange, S. M. N. 3\u2032,4\u2032-Dihydro-2\u2032H-spiro[indolin-3:1\u2032-isoquinolin]-2-ones as potential anticancer agents: synthesis and preliminary screening. R. Soc. Open Sci. 7, 191316. https:\/\/doi.org\/10.1098\/rsos.191316 (2020).","journal-title":"R. Soc. Open Sci."},{"key":"74824_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager, W. & Jensen, J. B. Human malaria parasites in continuos culture. Science 193, 673\u2013675. https:\/\/doi.org\/10.1126\/science.781840 (1976).","journal-title":"Science"},{"key":"74824_CR20","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein, M., Sriwilaijaroen, N., Kelly, J. X., Wilairat, P. & Riscoe, M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 48, 1803\u20131806. https:\/\/doi.org\/10.1128\/AAC.48.5.1803-1806.2004 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"74824_CR21","doi-asserted-by":"publisher","first-page":"7425","DOI":"10.1021\/jm5009693","volume":"57","author":"S Lee","year":"2014","unstructured":"Lee, S. et al. Discovery of carbohybrid-based 2-aminopyrimidine analogues as a new class of rapid-acting antimalarial agents using image-based cytological profiling assay. J. Med. Chem. 57, 7425\u20137434. https:\/\/doi.org\/10.1021\/jm5009693 (2014).","journal-title":"J. Med. Chem."},{"key":"74824_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijpddr.2017.02.002","volume":"7","author":"FR Bracken","year":"2017","unstructured":"Bracken, F. R. et al. 4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle. Int. J. Parasitol. Drugs Drug Resist. 7, 120\u2013129. https:\/\/doi.org\/10.1016\/j.ijpddr.2017.02.002 (2017).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"74824_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/835013","author":"PA Tarkang","year":"2014","unstructured":"Tarkang, P. A. et al. In vitro antiplasmodial activities and synergistic combinations of differential solvent extracts of the polyherbal product, nefang. Biomed. Res. Int. https:\/\/doi.org\/10.1155\/2014\/835013 (2014).","journal-title":"Biomed. Res. Int."},{"key":"74824_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41564-018-0111-0","volume":"3","author":"JA Thomas","year":"2018","unstructured":"Thomas, J. A. et al. A protease cascade regulates release of the human malaria parasite Plasmodium falciparum from host red blood cells. Nat. Microbiol. 3, 447\u2013455. https:\/\/doi.org\/10.1038\/s41564-018-0111-0 (2018).","journal-title":"Nat. Microbiol."},{"key":"74824_CR25","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1073\/pnas.1619441114","volume":"114","author":"VL Hale","year":"2017","unstructured":"Hale, V. L. et al. Parasitophorous vacuole poration precedes its rupture and rapid host erythrocyte cytoskeleton collapse in Plasmodium falciparum egress. PNAS 114, 3439\u20133444. https:\/\/doi.org\/10.1073\/pnas.1619441114 (2017).","journal-title":"PNAS"},{"key":"74824_CR26","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1128\/AAC.01881-12","volume":"57","author":"DW Wilson","year":"2013","unstructured":"Wilson, D. W., Langer, C., Goodman, C. D., McFadden, G. I. & Beesona, J. G. Defining the timing of action of antimalarial drugs against Plasmodium falciparum. Antimicrob. Agents Chemother. 57, 1455\u20131467. https:\/\/doi.org\/10.1128\/AAC.01881-12 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"74824_CR27","doi-asserted-by":"publisher","first-page":"e1007031","DOI":"10.1371\/journal","volume":"14","author":"C Lehmann","year":"2018","unstructured":"Lehmann, C. et al. Plasmodium falciparum dipeptidyl aminopeptidase 3 activity is important for efficient erythrocyte invasion by the malaria parasite. PLoS Pathog. 14, e1007031. https:\/\/doi.org\/10.1371\/journal (2018).","journal-title":"PLoS Pathog."},{"key":"74824_CR28","doi-asserted-by":"publisher","first-page":"e73530","DOI":"10.1371\/journal.pone.0073530","volume":"8","author":"R Prasad","year":"2013","unstructured":"Prasad, R. et al. Blocking Plasmodium falciparum development via dual inhibition of hemoglobin degradation and the ubiquitin proteasome system by MG132. PLoS ONE 8, e73530. https:\/\/doi.org\/10.1371\/journal.pone.0073530 (2013).","journal-title":"PLoS ONE"},{"key":"74824_CR29","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1128\/AAC.48.7.2370-2378.2004","volume":"48","author":"HC Hoppe","year":"2004","unstructured":"Hoppe, H. C. et al. Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum. Antimicrob. Agents Chemother. 48, 2370\u20132378. https:\/\/doi.org\/10.1128\/AAC.48.7.2370-2378.2004 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"74824_CR30","doi-asserted-by":"publisher","first-page":"15398","DOI":"10.1038\/s41598-019-51604-z","volume":"9","author":"T Herraiz","year":"2019","unstructured":"Herraiz, T., Guill\u00e9n, H., Gonz\u00e1lez-Pe\u00f1a, D. & Ar\u00e1n, V. J. Antimalarial quinoline drugs inhibit \u03b2-hematin and increase free hemin catalyzing peroxidative reactions and inhibition of cysteine proteases. Sci. Rep. 9, 15398. https:\/\/doi.org\/10.1038\/s41598-019-51604-z (2019).","journal-title":"Sci. Rep."},{"key":"74824_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.micro.51.1.97","volume":"51","author":"SE Francis","year":"1997","unstructured":"Francis, S. E., Sullivan, D. J. & Goldberg, D. E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51, 97\u2013123 (1997).","journal-title":"Annu. Rev. Microbiol."},{"key":"74824_CR32","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1128\/AAC.42.11.2973","volume":"42","author":"M Mungthin","year":"1998","unstructured":"Mungthin, M., Bray, P. G., Ridley, R. G. & Ward, S. A. Central role of hemoglobin degradation in mechanisms of action of 4-aminoquinolines, quinoline methanols, and phenanthrene methanols. Antimicrob. Agents Chemother. 42, 2973\u20132977 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"74824_CR33","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/540786","author":"MA Wijayanti","year":"2010","unstructured":"Wijayanti, M. A. et al. Additive in vitro antiplasmodial effect of N-alkyl and N-benzyl-1, 10-phenanthroline derivatives and cysteine protease inhibitor E64. Malar. Res. Treat. https:\/\/doi.org\/10.4061\/2010\/540786 (2010).","journal-title":"Malar. Res. Treat."},{"key":"74824_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1365-2958.2004.04284.x","volume":"54","author":"KE Jackson","year":"2004","unstructured":"Jackson, K. E. et al. Food vacuole-associated lipid bodies and heterogeneous lipid environments in the malaria parasite, Plasmodium falciparum. Mol. Microbiol. 54, 109\u2013122. https:\/\/doi.org\/10.1111\/j.1365-2958.2004.04284.x (2004).","journal-title":"Mol. Microbiol."},{"key":"74824_CR35","doi-asserted-by":"publisher","first-page":"22596","DOI":"10.1074\/jbc.M301407200","volume":"278","author":"CD Fitch","year":"2003","unstructured":"Fitch, C. D., Chen, Y. & Cai, G. Chloroquine-induced masking of a lipid that promotes ferriprotoporphyrin IX dimerization in malaria. J. Biol. Chem. 278, 22596\u201322599 (2003).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74824-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74824-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74824-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:16:28Z","timestamp":1670364988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74824-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["74824"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-74824-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"8 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17932"}}